Objectives: To illustrate that the protease inhibitor (PI) ritonavir, widely used as part of the treatment for HIV, might cause drug–drug interactions with inhaled corticosteroids.
Material and methods: A case report is presented.
Results: An HIV-positive patient presented with gradually changing body composition that was ascribed to lipodystrophy. Finally, iatrogenic Cushing's syndrome with secondary adrenal insufficiency was diagnosed due to a drug–drug interaction of ritonavir and fluticasone.
Conclusion: Lipodystrophy might mimic Cushing's syndrome. The combination of ritonavir and inhaled fluticasone may lead to systemic steroid excess causing Cushing's syndrome and secondary adrenal insufficiency.
HTML downloads: 700
PDF downloads: 880
Abstract downloads: 0
Authorsinformation downloads: 0
Conflicts of Interest Dr van Aken downloads: 0
Conflicts of interest Dr van Nieuwkoop downloads: 0
Conflicts of Interest Drs Vlasveld downloads: 0
Copyright of Authorization form downloads: 0
Figure1 downloads: 0
Informed consent patient downloads: 0
List references downloads: 0
Table1 downloads: 0
Issue: Vol. 1 (2014) (view)